Conidiobolomycosis: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Conidiobolomycosis | |||
| image = [[File:Conidiobolus_coronatus_(10.3897-mycokeys.66.46575)_Figure_4.jpg|250px]] | |||
| caption = ''Conidiobolus coronatus'' | |||
| field = [[Infectious disease]] | |||
| symptoms = [[Nasal congestion]], [[facial swelling]], [[sinusitis]] | |||
| complications = [[Orbital cellulitis]], [[meningitis]] | |||
| onset = Gradual | |||
| duration = Chronic | |||
| causes = [[Conidiobolus coronatus]], [[Conidiobolus incongruus]], [[Conidiobolus lamprauges]] | |||
| risks = [[Immunocompromised]] state, [[diabetes mellitus]] | |||
| diagnosis = [[Biopsy]], [[culture]], [[imaging studies]] | |||
| differential = [[Rhinosporidiosis]], [[aspergillosis]], [[mucormycosis]] | |||
| treatment = [[Antifungal medication]] (e.g., [[itraconazole]], [[amphotericin B]]) | |||
| prognosis = Variable, depends on early diagnosis and treatment | |||
| frequency = Rare | |||
}} | |||
'''Conidiobolomycosis''' is a rare and chronic subcutaneous [[mycosis]] caused by the fungus ''[[Conidiobolus]]'' species. This disease is primarily found in tropical and subtropical regions, and it affects both humans and animals. | '''Conidiobolomycosis''' is a rare and chronic subcutaneous [[mycosis]] caused by the fungus ''[[Conidiobolus]]'' species. This disease is primarily found in tropical and subtropical regions, and it affects both humans and animals. | ||
==Etiology== | ==Etiology== | ||
The causative agents of conidiobolomycosis are fungi from the ''Conidiobolus'' genus, particularly ''[[Conidiobolus coronatus]]'' and ''[[Conidiobolus incongruus]]''. These fungi are saprophytic and are commonly found in soil, decaying plant material, and the gastrointestinal tract of insects. | The causative agents of conidiobolomycosis are fungi from the ''Conidiobolus'' genus, particularly ''[[Conidiobolus coronatus]]'' and ''[[Conidiobolus incongruus]]''. These fungi are saprophytic and are commonly found in soil, decaying plant material, and the gastrointestinal tract of insects. | ||
==Epidemiology== | ==Epidemiology== | ||
Conidiobolomycosis is endemic in tropical and subtropical regions, including parts of Africa, South America, and Asia. The disease is more common in males and in individuals who are in close contact with soil and plant material, such as farmers and gardeners. | Conidiobolomycosis is endemic in tropical and subtropical regions, including parts of Africa, South America, and Asia. The disease is more common in males and in individuals who are in close contact with soil and plant material, such as farmers and gardeners. | ||
==Clinical Presentation== | ==Clinical Presentation== | ||
The disease typically presents as a painless, slowly enlarging subcutaneous nodule on the face or upper body. The overlying skin may appear normal or may exhibit erythema, induration, or ulceration. In some cases, the disease can spread to the lymph nodes and cause [[lymphadenopathy]]. | The disease typically presents as a painless, slowly enlarging subcutaneous nodule on the face or upper body. The overlying skin may appear normal or may exhibit erythema, induration, or ulceration. In some cases, the disease can spread to the lymph nodes and cause [[lymphadenopathy]]. | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of conidiobolomycosis is based on clinical presentation, histopathological examination, and fungal culture. The histopathological examination typically reveals granulomatous inflammation with eosinophilic material known as Splendore-Hoeppli phenomenon. | Diagnosis of conidiobolomycosis is based on clinical presentation, histopathological examination, and fungal culture. The histopathological examination typically reveals granulomatous inflammation with eosinophilic material known as Splendore-Hoeppli phenomenon. | ||
==Treatment== | ==Treatment== | ||
Treatment of conidiobolomycosis typically involves surgical excision of the lesion and antifungal therapy. The antifungal drugs of choice are [[itraconazole]] and [[amphotericin B]]. | Treatment of conidiobolomycosis typically involves surgical excision of the lesion and antifungal therapy. The antifungal drugs of choice are [[itraconazole]] and [[amphotericin B]]. | ||
==Prognosis== | ==Prognosis== | ||
The prognosis of conidiobolomycosis is generally good, especially with early diagnosis and treatment. However, the disease can cause significant morbidity due to disfigurement and functional impairment. | The prognosis of conidiobolomycosis is generally good, especially with early diagnosis and treatment. However, the disease can cause significant morbidity due to disfigurement and functional impairment. | ||
[[Category:Infectious diseases]] | [[Category:Infectious diseases]] | ||
[[Category:Mycoses]] | [[Category:Mycoses]] | ||
[[Category:Tropical diseases]] | [[Category:Tropical diseases]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
Latest revision as of 02:29, 5 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Conidiobolomycosis | |
|---|---|
| File:Conidiobolus coronatus (10.3897-mycokeys.66.46575) Figure 4.jpg | |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Nasal congestion, facial swelling, sinusitis |
| Complications | Orbital cellulitis, meningitis |
| Onset | Gradual |
| Duration | Chronic |
| Types | N/A |
| Causes | Conidiobolus coronatus, Conidiobolus incongruus, Conidiobolus lamprauges |
| Risks | Immunocompromised state, diabetes mellitus |
| Diagnosis | Biopsy, culture, imaging studies |
| Differential diagnosis | Rhinosporidiosis, aspergillosis, mucormycosis |
| Prevention | N/A |
| Treatment | Antifungal medication (e.g., itraconazole, amphotericin B) |
| Medication | N/A |
| Prognosis | Variable, depends on early diagnosis and treatment |
| Frequency | Rare |
| Deaths | N/A |
Conidiobolomycosis is a rare and chronic subcutaneous mycosis caused by the fungus Conidiobolus species. This disease is primarily found in tropical and subtropical regions, and it affects both humans and animals.
Etiology[edit]
The causative agents of conidiobolomycosis are fungi from the Conidiobolus genus, particularly Conidiobolus coronatus and Conidiobolus incongruus. These fungi are saprophytic and are commonly found in soil, decaying plant material, and the gastrointestinal tract of insects.
Epidemiology[edit]
Conidiobolomycosis is endemic in tropical and subtropical regions, including parts of Africa, South America, and Asia. The disease is more common in males and in individuals who are in close contact with soil and plant material, such as farmers and gardeners.
Clinical Presentation[edit]
The disease typically presents as a painless, slowly enlarging subcutaneous nodule on the face or upper body. The overlying skin may appear normal or may exhibit erythema, induration, or ulceration. In some cases, the disease can spread to the lymph nodes and cause lymphadenopathy.
Diagnosis[edit]
Diagnosis of conidiobolomycosis is based on clinical presentation, histopathological examination, and fungal culture. The histopathological examination typically reveals granulomatous inflammation with eosinophilic material known as Splendore-Hoeppli phenomenon.
Treatment[edit]
Treatment of conidiobolomycosis typically involves surgical excision of the lesion and antifungal therapy. The antifungal drugs of choice are itraconazole and amphotericin B.
Prognosis[edit]
The prognosis of conidiobolomycosis is generally good, especially with early diagnosis and treatment. However, the disease can cause significant morbidity due to disfigurement and functional impairment.
_Figure_4.jpg){kind=link}